PTK signaling plays an important role in the development of many diseases, including cancer, Alzheimer’s disease and diabetes mellitus, and the use of PTK inhibitors to treat disease is receiving increasing attention [8–10]. The gene discussed is PTK2B; the disease is early-onset autosomal dominant Alzheimer disease.